• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Study shows reduced hypoglycaemia after switch to Tresiba pharmatimes
    March 12, 2019
    New data from Novo Nordisk has shown that people with type I or type II diabetes who were switched to Tresiba (insulin degludec) by their doctor from other basal insulins achieved significantly reduced rates of hypoglycaemia, along with reduction in blood
  • Study shows reduced hypoglycaemia after switch to Tresiba pharmatimes
    March 12, 2019
    New data from Novo Nordisk has shown that people with type I or type II diabetes who were switched to Tresiba (insulin degludec) by their doctor from other basal insulins achieved significantly reduced rates of hypoglycaemia, along with reduction in blood

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service